drugset / Trial / NCT05803551

A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients

NCT05803551 ↗

Phase 2 Recruiting 50 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research is to study the effects of intravenous ketamine infusions for the treatment of patients with depressive symptoms in intensive care unit (ICU).

Timeline

Start
2025-07-07
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous

Indications